These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 1505835)
1. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study]. Shinwell ES; Zmora E; Leven D; Berger I; Karplus M Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835 [TBL] [Abstract][Full Text] [Related]
2. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group. Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230 [TBL] [Abstract][Full Text] [Related]
3. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150 [TBL] [Abstract][Full Text] [Related]
4. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176 [TBL] [Abstract][Full Text] [Related]
5. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480 [TBL] [Abstract][Full Text] [Related]
6. Surfactant and respiratory distress syndrome. Milner AD Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619 [TBL] [Abstract][Full Text] [Related]
7. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Dunn MS; Shennan AT; Zayack D; Possmayer F Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278 [TBL] [Abstract][Full Text] [Related]
8. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods. Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505 [TBL] [Abstract][Full Text] [Related]
9. Repeat surfactant therapy for postsurfactant slump. Katz LA; Klein JM J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122 [TBL] [Abstract][Full Text] [Related]
10. Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome. Dunn MS; Shennan AT; Possmayer F Pediatrics; 1990 Oct; 86(4):564-71. PubMed ID: 2216622 [TBL] [Abstract][Full Text] [Related]
11. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials. Kendig JW; Notter RH; Cox C; Aschner JL; Benn S; Bernstein RM; Hendricks-Munoz K; Maniscalco WM; Metlay LA; Phelps DL Pediatrics; 1988 Nov; 82(5):756-62. PubMed ID: 3054783 [TBL] [Abstract][Full Text] [Related]
12. [Surfactant treatment of premature infants with respiratory distress syndrome]. Saugstad OD; Gloppestad K Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941 [TBL] [Abstract][Full Text] [Related]
13. A prospective observational pilot study of synchronized nasal intermittent positive pressure ventilation (SNIPPV) as a primary mode of ventilation in infants > or = 28 weeks with respiratory distress syndrome (RDS). Santin R; Brodsky N; Bhandari V J Perinatol; 2004 Aug; 24(8):487-93. PubMed ID: 15141265 [TBL] [Abstract][Full Text] [Related]
14. Neonatal respiratory distress syndrome and surfactant therapy; a brief review. Robertson B Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999 [TBL] [Abstract][Full Text] [Related]
15. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome]. Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674 [TBL] [Abstract][Full Text] [Related]
16. Surfactant therapy in respiratory distress syndrome--the first local experience. Lim NL; Nordin MM; Cheah IG Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989 [TBL] [Abstract][Full Text] [Related]
17. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao. Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907 [TBL] [Abstract][Full Text] [Related]
18. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants. Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258 [TBL] [Abstract][Full Text] [Related]
19. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Soll RF; Morley CJ Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966 [TBL] [Abstract][Full Text] [Related]
20. Synthetic surfactant for respiratory distress syndrome in preterm infants. Soll RF Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]